Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. F /
  3. KK3A.F

Cytokinetics Incorporated (KK3A F) stock market data APIs

€53.5 0(0%) as of July 26, 2024
Price chart is built with Anychart

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated has a strategic alliance with Ji Xing Pharmaceuticals Limited. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Cytokinetics Incorporated Financial Data Overview

53.5
53.5
-
53.5
53.5
25.2-99.5
6 447 M
117 M
3 752 K
-0.86
0.753
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KK3A',
Type: 'Common Stock',
Name: 'Cytokinetics Incorporated',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

Cytokinetics Incorporated Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 752 K
  • EBITDA -485 592 000
  • Earnings Per Share -4.98
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Cytokinetics Incorporated Earnings via APIs

  • Latest Release 2021-08-05
  • EPS/Forecast -0.66

Get Cytokinetics Incorporated End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Cytokinetics Incorporated latest news via APIs

Cytokinetics to Announce Second Quarter Results on August 8, 2024

Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter resul...

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Cytokinetics (CYTK) reports results for the quarter ended June 2024. While this widely-known consensus outlook is impo...
Do you have any questions?
support@eodhistoricaldata.com